Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Peter Ankomah"'
Publikováno v:
PLoS Pathogens, Vol 9, Iss 4, p e1003300 (2013)
There are both pharmacodynamic and evolutionary reasons to use multiple rather than single antibiotics to treat bacterial infections; in combination antibiotics can be more effective in killing target bacteria as well as in preventing the emergence o
Externí odkaz:
https://doaj.org/article/a4ae0d61c9a0422c86e25c1d22b585c3
Autor:
Peter Ankomah, Bruce R Levin
Publikováno v:
PLoS Pathogens, Vol 8, Iss 1, p e1002487 (2012)
Multi-drug therapy is the standard-of-care treatment for tuberculosis. Despite this, virtually all studies of the pharmacodynamics (PD) of mycobacterial drugs employed for the design of treatment protocols are restricted to single agents. In this rep
Externí odkaz:
https://doaj.org/article/fc40cc7d2f024633babdaf6129e2b24a
Publikováno v:
Trends in Microbiology. 25:878-892
Most antibiotic use in humans is to reduce the magnitude and term of morbidity of acute, community-acquired infections in immune competent patients, rather than to save lives. Thanks to phagocytic leucocytes and other host defenses, the vast majority
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98c9a9bc63051f1e3decaf59c7429bda
https://doi.org/10.1016/j.tim.2017.07.005
https://doi.org/10.1016/j.tim.2017.07.005
Autor:
Bruce R. Levin, Peter Ankomah
The successful treatment of bacterial infections is the product of a collaboration between antibiotics and the host’s immune defenses. Nevertheless, in the design of antibiotic treatment regimens, few studies have explored the combined action of an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dbe0cd23161ab8d39aee4ef2e8ea1ff
https://europepmc.org/articles/PMC4060691/
https://europepmc.org/articles/PMC4060691/
Publikováno v:
PLoS Pathogens, Vol 9, Iss 4, p e1003300 (2013)
PLoS Pathogens
PLoS Pathogens
There are both pharmacodynamic and evolutionary reasons to use multiple rather than single antibiotics to treat bacterial infections; in combination antibiotics can be more effective in killing target bacteria as well as in preventing the emergence o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbc03e3cf89c95453f7bcbf16538b784
http://europepmc.org/articles/PMC3617031?pdf=render
http://europepmc.org/articles/PMC3617031?pdf=render
Publikováno v:
The Journal of antimicrobial chemotherapy. 63(4)
Sir, We read with great interest the article by Udekwu et al. on the relationship between bacterial cell density and antibiotic efficacy. These authors have nicely shown by using in vitro time–kill, MIC estimation and antibiotic bioassay experiment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96fb53231d3cf9e180de7e6427a0d285
https://pubmed.ncbi.nlm.nih.gov/19318362
https://pubmed.ncbi.nlm.nih.gov/19318362
Autor:
Ruthie Birger, Andrew F. Read, C. Jessica E. Metcalf, Nina Wale, Nimalan Arinaminpathy, Charles Brower, Ted Cohen, Silvie Huijben, Laura C. Pollitt, Troy Day, Peter Ankomah, Roger D. Kouyos, Eili Y. Klein, Nicole Mideo, David L. Smith, Sebastian Bonhoeffer, Bryan T. Grenfell, Tiffany L. Bogich, Geoffrey Chi-Johnston, Claire J. Standley, Pia Abel zur Wiesch, Joshua P. Metlay, Bryan Greenhouse
Publikováno v:
Proceedings of the Royal Society B: Biological Sciences
Proceedings. Biological sciences, vol 281, iss 1794
Proceedings. Biological sciences, vol 281, iss 1794
The evolution of resistance to antimicrobial chemotherapy is a major and growing cause of human mortality and morbidity. Comparatively little attention has been paid to how different patient treatment strategies shape the evolution of resistance. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43afe4d29f1d80411c029689ac4304b7
http://rspb.royalsocietypublishing.org/content/281/1794/20140566.short
http://rspb.royalsocietypublishing.org/content/281/1794/20140566.short
Autor:
Roger D., Kouyos, C. Jessica E., Metcalf, Ruthie, Birger, Eili Y., Klein, Pia, Abel zur Wiesch, Peter, Ankomah, Nimalan, Arinaminpathy, Tiffany L., Bogich, Sebastian, Bonhoeffer, Charles, Brower, Geoffrey, Chi-Johnston, Ted, Cohen, Troy, Day, Bryan, Greenhouse, Silvie, Huijben, Joshua, Metlay, Nicole, Mideo, Laura C., Pollitt, Andrew F., Read, David L., Smith
Publikováno v:
Proceedings of the Royal Society B: Biological Sciences; 11/7/2014, Vol. 281 Issue 1794, p1-8, 8p
Publikováno v:
Journal of Antimicrobial Chemotherapy (JAC); Apr2009, Vol. 63 Issue 4, p745-745, 1p